Similar to PSD95, the interruption of the GluN2B-DAPK1 interaction via an interfering peptide or via the genetic deletion of DAPK1 provided protection against brain damage in ischemic stroke [101]. The gene discussed is DAPK1; the disease is ischemic stroke.